USPTO serial 98404511
PLAYSAFE
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- PETTICAN, NATHANIEL VINCIENT
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with PLAYSAFE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $549*
Plus Government fees of $600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Crumlin, County Antrim, GB
Crumlin, County Antrim, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Douglas N. Masters
Douglas N. Masters Loeb & Loeb LLP321 North Clark Street, Suite 2300Chicago, IL 60654United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides, and parasiticides; Diagnostic preparations for scientific purposes; Chemical reagents, other than for medical or veterinary purposes; Enzymes and proteins for industrial use; Diagnostic preparations for analysis of food products and water for scientific and research purposes; Clinical diagnostics preparations for scientific use; Diagnostic scanning agents for scientific use; Diagnostic testing materials for scientific use; Replacement parts and fittings for all the aforesaid goods | ACTIVE | — |
| 005 | Pharmaceutical, veterinary and sanitary preparations and substances for use in medical clinical analysis and testing in connection with diagnosing cardiovascular diseases, coronary heart disease, brain diseases, cancer, diabetes, kidney diseases, renal diseases, anemia, dementia, nervous system dysfunctions, diseases of the central nervous system, autoimmune diseases, allergy, vascular diseases, infertility, menopause, early or delayed puberty, reproductive or non-reproductive disorders, gastrointestinal disorders, digestive diseases and conditions, metabolic diseases, hypercalcemia, thyroid diseases, bone disorders, respiratory diseases, infectious diseases, sexually transmitted diseases, and urinary tract infections, testing high or low levels of testosterone, testing for calcium absorption, testing of blood levels, antimicrobial testing, and screening for drug use; blood sera and blood anti-sera, for medical and veterinary use; diagnostic preparations for medical purposes; diagnostic preparations and substances for medical and veterinary purposes; kits for medical purposes comprised of pharmaceutical preparations for use in medical clinical analysis and testing in connection with diagnosing cardiovascular diseases, coronary heart disease, brain diseases, cancer, diabetes, kidney diseases, renal diseases, anemia, dementia, nervous system dysfunctions, diseases of the central nervous system, autoimmune diseases, allergy, vascular diseases, infertility, menopause, early or delayed puberty, reproductive or non-reproductive disorders, gastrointestinal disorders, digestive diseases and conditions, metabolic diseases, hypercalcemia, thyroid diseases, bone disorders, respiratory diseases, infectious diseases, sexually transmitted diseases, and urinary tract infections, testing high or low levels of testosterone, testing for calcium absorption, testing of blood levels, antimicrobial testing, and screening for drug use; clinical diagnostics preparations, for medical or veterinary use; clinical diagnostic reagents for in vitro and vivo use; diagnostic scanning agents for in vivo use; diagnostic testing materials for medical and veterinary use; clinical medical reagents; reagents for use in diagnostic tests for medical and veterinary purposes; reagents for use with analyzers for medical and veterinary purposes; replacement parts and fittings for all the aforesaid goods | ACTIVE | — |
| 010 | Medical diagnostic kits, consisting of containers, analyzers and disposable cartridges, namely, apparatus for processing, testing and analyzing of bodily fluids; medical diagnostic kits, consisting of containers, analyzers and disposable cartridges, namely, apparatus for testing or detecting sexually transmitted infections (STI); clinical laboratory analytical instruments for medical or veterinary use, namely, for the analysis of bodily fluids, for use in in vitro diagnostic testing procedures, and for use with clinical chemistry analyzers, blood testing apparatus, and diagnostic saliva vials | ACTIVE | — |
| 044 | Medical services; hygienic and beauty care for human beings; consulting services relating to health care; health advice and information services; medical care services; health clinic services; healthcare services; medical consultations and lifestyle consultations, namely, professional consultations to individuals to assess their personal health and wellbeing; medical health assessment services; health screening services; diagnostic health screening services; preparation of reports relating to health care matters; professional consultancy relating to health; medical testing; medical diagnostic testing; nursing services; nursing care services; medical health and fitness assessment services; medical advisory and consultancy services relating to immunology; advisory and consultancy services relating to nutrition; cholesterol testing; genetic testing for medical purposes; hearing tests; services for the testing of blood; services for the testing of sera; services for the testing of urine; services for testing of bone functions; services for testing of major body organs; services for the testing of fertility hormone levels; health screening for pregnant women; pregnancy testing; prenatal care services; postnatal care services; services for the testing of diabetes; services for the testing of thyroid function; services for testing iron levels; medical assistance; medical clinics; information, consultancy and advice relating to any of the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Randox Laboratories Limited
- Other trademarks owned by Randox Laboratories Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named PLAYSAFE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 12, 2026 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Jun 9, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 8, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 8, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 8, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 9, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 14, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 14, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 8, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 19, 2025 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Sep 11, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 7, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Mar 6, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 6, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 6, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 5, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 5, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 5, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 5, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Dec 5, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Sep 6, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 6, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 6, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 6, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 12, 2024 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jun 15, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 13, 2024 | NWAP | NEW APPLICATION ENTERED | — |